Literature DB >> 2548143

N-myc activation by proviral insertion in MCF 247-induced murine T-cell lymphomas.

R Dolcetti1, S Rizzo, A Viel, R Maestro, V De Re, G Feriotto, M Boiocchi.   

Abstract

N-myc proto-oncogene rearrangement was found in three out of six AKR murine T-cell lymphomas induced by the highly oncogenic MCF 247 MuLV. Molecular analyses showed that structural modification of the proto-oncogene in all three lymphomas was in the consequence of MCF 247 proviral integration within the gene III exon. All integrated proviruses have the same transcriptional orientation as the N-myc gene. As a consequence of proviral insertion, the N-myc gene becomes transcriptionally active, producing an abnormal mRNA. These findings suggest a possible causative role of such an integrative event in murine T-cell lymphomagenesis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548143

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

1.  The common retroviral insertion locus Dsi1 maps 30 kilobases upstream of the P1 promoter of the murine Runx3/Cbfa3/Aml2 gene.

Authors:  Monica Stewart; Nancy MacKay; Ewan R Cameron; James C Neil
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  Identification of a common viral integration region in Cas-Br-E murine leukemia virus-induced non-T-, non-B-cell lymphomas.

Authors:  D Bergeron; L Poliquin; C A Kozak; E Rassart
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

3.  Tumor progression locus 2 (Tpl-2) encodes a protein kinase involved in the progression of rodent T-cell lymphomas and in T-cell activation.

Authors:  C Patriotis; A Makris; S E Bear; P N Tsichlis
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

4.  Hepadnavirus integration: mechanisms of activation of the N-myc2 retrotransposon in woodchuck liver tumors.

Authors:  Y Wei; G Fourel; A Ponzetto; M Silvestro; P Tiollais; M A Buendia
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

5.  IgH enhancer deregulated expression of L-myc: abnormal T lymphocyte development and T cell lymphomagenesis.

Authors:  T Möröy; P Fisher; C Guidos; A Ma; K Zimmerman; A Tesfaye; R DePinho; I Weissman; F W Alt
Journal:  EMBO J       Date:  1990-11       Impact factor: 11.598

6.  High frequency of myelomonocytic tumors in aging E mu L-myc transgenic mice.

Authors:  T Möröy; P E Fisher; G Lee; P Achacoso; F Wiener; F W Alt
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.